Iron Triangle Partners LP Has $27.91 Million Stock Holdings in Tenet Healthcare Corporation $THC

Iron Triangle Partners LP cut its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 27.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 137,448 shares of the company’s stock after selling 52,552 shares during the quarter. Tenet Healthcare makes up about 4.0% of Iron Triangle Partners LP’s investment portfolio, making the stock its 10th largest position. Iron Triangle Partners LP owned 0.16% of Tenet Healthcare worth $27,907,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in THC. Norges Bank bought a new stake in Tenet Healthcare in the second quarter worth $206,981,000. Eminence Capital LP bought a new position in Tenet Healthcare during the 3rd quarter valued at approximately $225,263,000. Boston Partners grew its position in shares of Tenet Healthcare by 95.0% in the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after buying an additional 1,104,500 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares during the period. Finally, Alliancebernstein L.P. raised its holdings in shares of Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after acquiring an additional 624,125 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on THC. Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, March 1st. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Truist Financial upped their price target on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Finally, KeyCorp raised their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $250.56.

Tenet Healthcare Price Performance

THC opened at $227.79 on Monday. The firm has a market cap of $19.81 billion, a PE ratio of 14.71, a P/E/G ratio of 1.10 and a beta of 1.39. The stock has a 50-day moving average price of $213.46 and a 200-day moving average price of $204.31. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period in the prior year, the firm posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the sale, the executive vice president owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 46,517 shares of company stock valued at $10,943,111. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.